CTXR vs SWK · rev $7.1M vs P/E 34, rev $7.81B
Citius Pharmaceuticals Inc (CTXR) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
CTXR currently screens at market cap $13.4M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the CTXR and SWK stock pages for the full models.
Not investment advice.